Given that the underlying causes of liver cancer in Chinese populations are different from those in Europe, this study was designed to investigate whether SEPT9 methylation can be detected in the plasma of HCC patients in Chinese populations and subsequently be used as a noninvasive marker for HCC detection. This evidence concerns the gene SEPTIN9 and hepatocellular carcinoma.